A 60-year-old male presents with Cancer prostate. The tumor is limited to the capsule and it is palpable on PR examination. The patient is diagnosed as stage T1b. The best treatment would be:
## **Core Concept**
The question revolves around the management of early-stage prostate cancer, specifically focusing on the staging and appropriate treatment modalities. Prostate cancer staging, often using the TNM system, guides treatment decisions. The patient's diagnosis of T1b indicates a tumor that is not palpable on a digital rectal examination (DRE) but is incidentally found in less than 5% of the prostate tissue during a transurethral resection of the prostate (TURP). However, given the details, there seems to be a discrepancy as T1b typically refers to a non-palpable tumor found incidentally, contradicting the palpable description.
## **Why the Correct Answer is Right**
The best treatment for early-stage prostate cancer, particularly for tumors that are organ-confined and of low to intermediate risk, often involves active surveillance, radiation therapy (including external beam radiation therapy or brachytherapy), or radical prostatectomy. Given the information provided and typical management strategies, **radical prostatectomy** or **radiation therapy** could be considered suitable for a palpable tumor limited to the capsule, suggesting an early but potentially more locally advanced stage than T1b implies. However, assuming a more standard approach for a tumor confined within the prostate capsule and considering common practices, surgery or radiotherapy could be optimal.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** Similarly, this option lacks information to assess its accuracy.
- **Option C:** Without specifics, it's challenging to deem this option incorrect directly.
- **Option D:** This option also lacks detail, making it hard to label as incorrect based on provided information.
## **Clinical Pearl / High-Yield Fact**
A key point in managing prostate cancer is that the treatment choice significantly depends on the cancer stage, patient's overall health, life expectancy, and the risk stratification of the cancer (based on PSA levels, Gleason score, and clinical stage). For localized disease, active surveillance, surgery, or radiation are mainstays, with the goal of curing the disease or controlling it effectively.
## **Correct Answer:** .